Why the study?
The study was conducted to assess the effects of a targeted and tailored pharmacist-led intervention among patients with type 2 diabetes who are nonadherent to antihypertensive drugs.
Does a targeted and tailored pharmacist-led intervention improve adherence to antihypertensive drugs in nonadherent patients with type 2 diabetes?
Population
113 patients with type 2 diabetes nonadherent to antihypertensive drugs across 10 community health centres in Indonesia
Comparison
Tailored pharmacist-led intervention vs usual care
Design
Cluster-randomised controlled trial
Follow-up
3-month follow-up
Authors
Loading...
Supports pharmacist-led tailoring to boost antihypertensive adherence in nonadherent T2D patients; extends adherence evidence to this subgroup.
Does a targeted and tailored pharmacist-led intervention improve adherence to antihypertensive drugs in nonadherent patients with type 2 diabetes?
A tailored pharmacist-led intervention significantly improved self-reported medication adherence to antihypertensive drugs among nonadherent patients with type 2 diabetes, though it did not significantly change blood pressure.
Alfian et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: